Infectious: Page 4

FDA grants priority review to Merck’s pneumococcal vaccine

By LabPulse.com staff writers

The U.S. Food and Drug Administration (FDA) has granted priority review to Merck’s experimental pneumococcal vaccine, with a decision to be made on approval by June 17, 2024.

December 20, 2023

AstraZeneca to buy Icosavax in agreement worth up to $1.1B

By LabPulse.com staff writers

AstraZeneca has agreed to buy vaccine developer Icosavax in a deal worth up to $1.1 billion.

December 13, 2023

CDC awards contract to Quest Diagnostics to assess hepatitis C burden

By LabPulse.com staff writers

Quest Diagnostics has been awarded a multiyear contract by the U.S. Centers for Disease Control and Prevention (CDC) to assess the burden of hepatitis C virus (HCV) in the U.S.

December 7, 2023

U.K. researchers use deep learning to develop rapid antimicrobial resistance test

By Matt Limb

Researchers are hailing progress toward more rapid detection of antimicrobial resistance (AMR), with a susceptibility test returning results in 30 minutes.

December 1, 2023

Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test

By LabPulse.com staff writers

Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.

November 22, 2023

Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution

By Matt Limb

Oxford, U.K.-based Oxford Nanopore Technologies and Boston-based infectious disease diagnostics firm Day Zero Diagnostics have announced a partnership to develop an end-to-end solution for the diagnosis of bloodstream infections.

November 20, 2023

Cytovale raises $84M in series C funding

By LabPulse.com staff writers

Medical technology firm Cytovale has raised $84 million in a series C financing round that the firm says it will use to expand the commercialization of its 10-minute IntelliSep test.

November 16, 2023

Illumina launches pricing program for pathogen sequencing tools in LMICs

By LabPulse.com staff writers

Illumina has launched its Global Health Access Initiative program to provide pathogen sequencing tools at lower prices in low- and middle-income countries (LMICs).

November 13, 2023

AI model could predict viral mutation, aid vaccine design

By Matt Limb

Researchers have developed a new artificial intelligence (AI) tool which they say could help predict new viral variants before they emerge.

October 31, 2023

WHO launches expert review panel for NTD diagnostics

By LabPulse.com staff writers

The World Health Organization (WHO) has created a pilot scheme for an expert review panel for diagnostic products as part of its program for neglected tropical diseases (NTDs).

October 13, 2023

NIH researchers develop PCR assay for easier diagnosis of river blindness

By LabPulse.com staff writers

U.S. National Institutes of Health (NIH) researchers have developed a new PCR assay to detect Onchocerca volvulus, the parasite that causes onchocerciasis, or river blindness, and are working to adapt it for easier field diagnosis of the disease.

October 9, 2023

BioMérieux subsidiary secures DoD contract for infectious disease testing system

By LabPulse.com staff writers

BioFire Defense, a subsidiary of BioMérieux, has secured an order-dependent contract with the U.S. Department of Defense (DoD) to provide support for a military-use version of its multiplex polymerase chain reaction infectious disease test system.

September 29, 2023

Previous Page

Page 4 of 152

Next Page